Uncategorized

Biogen to buy Apellis for $5.6B

Published

1 week ago

on

March 31, 2026

By

Temp User

Biogen has made a $5.6 billion deal to acquire Apellis Pharmaceuticals, the companies announced Tuesday.

The deal will allow Biogen to get hold of the kidney disease drug Empaveli and the eye disease therapy Syfovre …

Related Topics:

Leave a Reply

Uncategorized9 years ago

These ’90s fashion trends are making a comeback in 2017
Contributors9 years ago

The final 6 ‘Game of Thrones’ episodes might feel like a full season
Uncategorized9 years ago

According to Dior Couture, this taboo fashion accessory is back
Uncategorized9 years ago

The old and New Edition cast comes together to perform
Uncategorized9 years ago

Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uncategorized9 years ago

Uber and Lyft are finally available in all of New York State

Exit mobile version